22 patents
Page 2 of 2
Utility
Compositions and Methods for Adoptive Cell Therapies
15 Apr 20
Provided herein are immune cells engineered to express one or more cell surface receptor polypeptides containing activatable antigen receptor polypeptides, and methods of use thereof for the treatment of diseases, including cancer.
Luke EVNIN, Holger WESCHE, Kevin WRIGHT
Filed: 2 May 18
Utility
DLL3 Binding Proteins and Methods of Use
25 Mar 20
Provided herein are DLL3 binding proteins and DLL3 targeting multispecific proteins (e.g., DLL3 targeting trispecific protein) comprising a domain binding to CD3, a half-life extension domain, and a domain binding to DLL3 (such as a DLL3 binding protein as provided herein).
Holger WESCHE, Richard J. Austin
Filed: 24 Sep 19